Please login or register to print this page.

VIEW TAGS

Articles tagged ‘stroke prevention’

October 30, 2015

Switching patients with AF to NOACs in primary care

Non-vitamin K antagonist oral anticoagulants (NOACs) constitute “a new era in anticoagulation therapy” for patients with atrial fibrillation (AF), according to a review published recently in the International Journal of General Medicine.1

read more

December 19, 2014

New European atlas on the prevention of AF-related stroke launched

The burden of atrial fibrillation (AF)-related stroke prevention in different countries across Europe is shown by a comprehensive new report – ‘The Route Map for Change and European Atlas on the Prevention of AF-related Stroke’ – released recently the Arrhythmia Alliance.

read more

August 5, 2014

Apixaban cost-effective in stroke prevention

Based on randomised trial data, apixaban is a cost-effective alternative to warfarin and aspirin, in vitamin K antagonists (VKA) suitable and VKA unsuitable patients with AF, respectively, according to a recent study.1

read more

February 28, 2013

Stepwise AF screening in the elderly

Stepwise risk factor-stratified atrial fibrillation (AF) screening in a 75-year old plus population yields a large share of candidates for oral anticoagulant (OAC) treatment, according to a study1 published recently in Circulation.

read more

February 28, 2013

Outcomes with aspirin versus apixaban in patients with AF

In an atrial fibrillation (AF) population, apixaban was superior to aspirin for stroke prevention. There were similar rates of major bleeding, in the presence of one or more stroke risk factors, with consistency of the treatment effect by CHADS2/CHA2DS2-VASc scores, according to a study1 published recently in Circulation: arrhythmia and electrophysiology.

read more

November 3, 2011

Aspirin unsafe and ineffective for stroke prevention in AF

Aspirin increases the risk of bleeding without decreasing the risk of stroke/thromboembolism sufficiently in patients with atrial fibrillation (AF), according to a study1 published recently in Thrombosis and Haemostasis.

read more

September 7, 2011

LANDMARK STUDY ON TREATMENT OPTIONS FOR AF

The first patient has been enrolled, in Hamburg, Germany, for the largest pan-European study to determine whether an early comprehensive rhythm control strategy for the treatment of atrial fibrillation (AF) will benefit patients.

read more

May 6, 2011

DABIGATRAN RECOMMENDED FOR EUROPE-WIDE AF APPROVAL

Dabigatran etexilate has recently been recommended for approval in EU member states by the Committee for Medicinal Products for Human Use (CHMP), for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (AF).

read more

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.